Proteome Sciences (LON:PRM) Stock Price Down 13.7% – Here’s What Happened

Proteome Sciences plc (LON:PRM)’s share price fell 13.7% on Tuesday . The stock traded as low as GBX 2.90 ($0.04) and last traded at GBX 2.90 ($0.04). 384,621 shares traded hands during trading, an increase of 77% from the average session volume of 217,435 shares. The stock had previously closed at GBX 3.36 ($0.05).

Proteome Sciences Stock Down 2.9%

The firm has a 50 day simple moving average of GBX 3.09 and a two-hundred day simple moving average of GBX 3.55. The company has a debt-to-equity ratio of -258.66, a quick ratio of 0.37 and a current ratio of 0.20. The stock has a market cap of £8.86 million, a P/E ratio of -2.17 and a beta of 0.07.

Proteome Sciences (LON:PRM) last announced its earnings results on Thursday, April 10th. The company reported GBX (1.15) (($0.02)) earnings per share for the quarter. Proteome Sciences had a negative net margin of 0.04% and a negative return on equity of 0.01%.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.